regorafenib and Melanoma

regorafenib has been researched along with Melanoma* in 1 studies

Reviews

1 review(s) available for regorafenib and Melanoma

Article	Year
Small molecule inhibitors of BRAF in clinical trials. Bioorganic & medicinal chemistry letters, 2012, Jan-15, Volume: 22, Issue:2 Over the last few years, BRAF has emerged as a validated target in melanoma. This review summarises recent advances in the development of BRAF inhibitors, focussing on agents that have been assessed clinically. Topics: Clinical Trials as Topic; Humans; Melanoma; Molecular Weight; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship	2012

Article

Year

Small molecule inhibitors of BRAF in clinical trials.

Bioorganic & medicinal chemistry letters, 2012, Jan-15, Volume: 22, Issue:2

Over the last few years, BRAF has emerged as a validated target in melanoma. This review summarises recent advances in the development of BRAF inhibitors, focussing on agents that have been assessed clinically.

Topics: Clinical Trials as Topic; Humans; Melanoma; Molecular Weight; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship

2012